Jeff Fairman - Oct 26, 2022 Form 4 Insider Report for Vaxcyte, Inc. (PCVX)

Role
VP, Research
Signature
Jeff Fairman, by /s/ Ron A. Metzger, Attorney-in-Fact
Stock symbol
PCVX
Transactions as of
Oct 26, 2022
Transactions value $
-$400,000
Form type
4
Date filed
10/28/2022, 06:56 PM
Previous filing
Oct 13, 2022
Next filing
Jan 4, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PCVX Common Stock Sale -$400K -10K -3.38% $40.00 286K Oct 26, 2022 By Fairman Family Trust F1
holding PCVX Common Stock 17.1K Oct 26, 2022 Direct
holding PCVX Common Stock 50K Oct 26, 2022 By AF 2020 Irrevocable Trust
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan.